Evidence map›Paper›PMID 42326968›Full record

ArticleCase reports in hematology2026

The Challenge of Differentiating Mixed Histiocytosis: A Case Report.

Lydia Harris, Rosalia Arnolda, David Ogburn, Padmaja Mallidi

Abstract read
In one paragraph

Article in Case reports in hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lydia HarrisDepartment of Internal Medicine, Carilion Clinic, Roanoke, Virginia, USA, carilionclinic.org.ORCID https://orcid.org/0009-0006-5695-9300
Rosalia ArnoldaDepartment of Internal Medicine, Carilion Clinic, Roanoke, Virginia, USA, carilionclinic.org.ORCID https://orcid.org/0009-0007-3055-3086
David OgburnSchool of Medicine, Virginia Tech, Blacksburg, Virginia, USA, vt.edu.ORCID https://orcid.org/0009-0000-9047-1954
Padmaja MallidiDepartment of Oncology, Carilion Clinic, Roanoke, Virginia, USA, carilionclinic.org.ORCID https://orcid.org/0009-0006-7738-8295

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Langerhans cell histiocytosis (LCH) and Erdheim-Chester Disease (ECD) are two forms of histiocytic disease with some overlapping features. They can have multisystem involvement, which makes it a diagnostic challenge. In this report, we present a patient who was diagnosed with both LCH and ECD over the span of 7 years. A 69-year-old female with a past medical history of hypertension, hyperlipidemia, and diabetes mellitus presented with right ear pressure and was subsequently diagnosed with LCH after a mastoid bone biopsy in 2017. She then underwent mass resection. Two years later, during an abdominal MRI for evaluation of cholestatic disease, a large pericardial effusion with pericardial thinning was discovered. Cardiac MRI was concerning for a soft tissue mass anterior and superior to the right atrium, suggestive of infiltrative processes such as histiocytosis. Seven years after the initial presentation, she underwent a pericardial biopsy that diagnosed ECD. It is important to recognize that even though mixed disease is rare, clinical suspicion needs to be high. This is particularly true for patients with cardiac features that would be atypical in LCH to ensure prompt treatment.

Indexed as

Erdheim–Chester diseaseLangerhans cell histiocytosispericardial effusion

Identifiers

PMID42326968
PMCPMC13277757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.